Author:
Dickason-Chesterfield Amy K.,Kidd Stephanie R.,Moore Steven A.,Schaus John M.,Liu Bin,Nomikos George G.,Felder Christian C.
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Cellular and Molecular Neuroscience,General Medicine
Reference50 articles.
1. Aquila, B. A., Hopkins, S., Lockshin, C. A., and Wang, F. (2003). Sepracor. Amines that inhibit a mammalian anandamide transporter, and methods of use thereof. WO03097573.
2. Baker, D., Pryce, G., Davies, W. L., and Hiley, C. R. (2006). In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol. Sci. 27(1):1–4.
3. Begg, M., Pacher, P., Batkai, S., Osei-Hyiaman, D., Offertaler, L., Mo, F. M., Liu, J., and Kunos, G. (2005). Evidence for novel cannabinoid receptors. Pharmacol. Ther. 106(2):133–145.
4. Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., and Piomelli, D. (1997). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277(5329):1094–1097.
5. Boyd, S. T., and Fremming, B. A. (2005). Rimonabant–a selective CB1 antagonist. Ann. Pharmacother. 39(4):684–690.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献